fibrinogen has been researched along with Hot Flashes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crandall, CJ; El Khoudary, SR; Gold, E; Matthews, KA; Selzer, F; Sternfeld, B; Sutton-Tyrrell, K; Thurston, RC | 1 |
Ebano, V; Fruscella, M; Imperato, F; Marziani, R; Mossa, B; Perniola, G | 1 |
Ehrlich, K; Grothaus, LC; LaCroix, AZ; Newton, KM; Reed, SD; Spangler, L | 1 |
Archer, DF; Gut, R; Lang, E; Panay, N; Ylikorkala, O | 1 |
2 trial(s) available for fibrinogen and Hot Flashes
Article | Year |
---|---|
The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin.
Topics: Blood Glucose; Cimicifuga; Double-Blind Method; Estrogen Replacement Therapy; Female; Fibrinogen; Hot Flashes; Humans; Insulin; Lipids; Menopause; Middle Aged; Phytoestrogens; Phytotherapy; Treatment Outcome | 2007 |
Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
Topics: Adult; Aged; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Hot Flashes; Humans; Hydrogen-Ion Concentration; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Severity of Illness Index; Vagina | 2007 |
2 other study(ies) available for fibrinogen and Hot Flashes
Article | Year |
---|---|
Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation.
Topics: Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive Protein; Estradiol; Factor VII; Female; Fibrinogen; Hemostasis; Hot Flashes; Humans; Inflammation; Longitudinal Studies; Menopause; Middle Aged; Sweating; Tissue Plasminogen Activator; Vasomotor System; Women's Health | 2011 |
[Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
Topics: Administration, Cutaneous; Antithrombin III; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Depression; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Follow-Up Studies; Hot Flashes; Humans; Hyperlipidemias; Hysterectomy; Italy; Lipids; Middle Aged; Ovariectomy; Platelet Count; Prospective Studies; Risk Factors; Tamoxifen; Triglycerides | 2003 |